Skip to main content
K

KIMIA BIOSCIENCES LIMITED — Investor Relations & Filings

Ticker · 530313 ISIN · INE285U01025 LEI · 335800FH7DQH7G1ONN19 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 530313

About KIMIA BIOSCIENCES LIMITED

https://www.kimiabiosciences.com/

Kimia Biosciences Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization focuses on therapeutic segments addressing lifestyle diseases, including diabetes, hypertension, and dyslipidemia. Its product portfolio includes key molecules such as Vildagliptin, Sitagliptin, and Teneligliptin, alongside various other complex chemical entities. The company prioritizes Research and Development (R&D) to drive process innovation, cost-efficiency, and adherence to international quality benchmarks. By leveraging technical expertise in chemical synthesis and large-scale production, the entity provides critical raw materials and strategic manufacturing solutions to the global healthcare supply chain.

Recent filings

No filings indexed yet

We are still gathering filings for KIMIA BIOSCIENCES LIMITED. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.